Bubble Intelligence

Market Intelligence For The New Regime

WEST PHARMACEUTICAL SERVICES INC
WSTwestpharma.com
Latest Filing: Apr 23, 2026 • 25 Total Filings
Total Assets
2026
$4.11B
Total Revenue
2026
$844.90M
Net Income
2026
$138.80M
Operating Cash Flow
2026
$89.90M
Filing Year:
2025
Only 2025 data available
Data Source:
Showing data from all document types
Filters:
located incompetes withcompetes withcompetes withcompetes withcompetes withcompetes with
WEST PHARMACEUTICAL SERVICES INC
Ticker: WST
Unknown Region
1 supplier
Daikyo
licensor
⚠ Critical
Datwyler
Proprietary Products components
Major Competitor
Aptar
Proprietary Products components
Major Competitor
SMC Ltd.
Contract-Manufactured Products device manufacturing
Phillips Medisize
Contract-Manufactured Products device manufacturing
Sharp
Contract-Manufactured Products, scalable drug packaging and assembly
PCI Pharma Services
Contract-Manufactured Products, scalable drug packaging and assembly
React Flow
Legend:
Company
Critical Supplier
Significant Supplier
Standard Supplier
Major Competitor
Emerging Competitor
Competitor
Regional Supplier Concentration
0 regions with known supplier geography · 1 supplier without location data
Risk:LowModerateElevatedHigh
1 supplier · no geography